 |
|
|
|
|
|
GMO is a global investment management firm committed to providing sophisticated clients with superior asset management solutions and services. We offer a broad range of investment products, including equity and fixed income strategies across global developed and emerging markets, as well as absolute return strategies. Our client base includes endowments, pension funds, public funds, foundations and cultural institutions.
GMO is a private partnership that employs more than 400 people worldwide. Investment management is our only business. We manage more than $78 billion in client assets, $27 billion of which is in asset allocation strategies.
Our global offices include the firm's headquarters in Boston and offices in San Francisco, London, Zurich, Singapore and Sydney. For more information on GMO, please see About GMO.
To read Jeremy Grantham's 1Q 2009 letter, please click the title. (Acrobat Reader Version 7 or higher is recommended.)
As mentioned below, in order to view selected market commentary, you must register with our website. In addition, registering gives you access to information about the GMO Trust Funds, including the GMO Trust Prospectus and Statement of Additional Information, annual and semi-annual reports, and information regarding how the GMO Trust Funds voted proxies relating to their portfolio securities.
|
|
| Recent Market Commentary |
| In order to view market commentary, you must register on our website. Please login if you are a registered user. |
The Last Hurrah and Seven Lean Years - Jeremy Grantham
1Q 2009 GMO Quarterly Update - GMO Investment Teams
Valuing Equities in an Economic Crisis - Ben Inker
Reinvesting When Terrified - Jeremy Grantham
Grantham's Big Call - Steve Forbes
When Diversification Failed - Ben Inker
|
|
|
|
|
|